NCT06161285

Brief Summary

Acute bronchiolitis is a common disease in children under the age of two, caused mainly by the respiratory syncytial virus (RSV). Furthermore, given the same medical history, it is still very difficult to predict the course and severity of the infection at the onset of symptoms, Some studies have highlighted the importance of the microbiota (intestinal, oral or nasopharyngeal) and of the immune response to RSV in children, We will include 80 children under 2 years old with hospitalized bronchiolitis and non-hospitalized bronchiolitis. Oral, nasal and stool samples will be taken to study the various microbiota in search of dysbiosis. A capillary blood sample will be taken for immune studies.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 7, 2023

Completed
1 year until next milestone

Study Start

First participant enrolled

December 6, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

February 26, 2025

Status Verified

January 1, 2025

Enrollment Period

1.2 years

First QC Date

November 30, 2023

Last Update Submit

February 24, 2025

Conditions

Keywords

NewbornsDysbiosisrespiratory syncytial virus (RSV)

Outcome Measures

Primary Outcomes (1)

  • Dysbiosis

    comparison of the quantitative and qualitative composition of bacteria (alpha diversity, beta diversity, Shannon and Simpson index) in the digestive and nasopharyngeal microbiota

    Inclusion

Secondary Outcomes (5)

  • Measurement of innate and adaptive responses by quantification of cytokines and chemokines in plasma

    inclusion

  • Identifying the mRNA profile in blood samples and nasal swabs

    inclusion

  • Sequencing viral strains for mutation

    Inclusion

  • Comparison of respiratory syncytial virus (RSV) antibodies levels on newborn screening specimen and on capillary swab during infection

    Birth, Inclusion

  • Study the load of Streptococcus pneumoniae (Sp) in RSV infections.

    Inclusion

Study Arms (3)

Severe bronchiolitis

venous blood samples. Buccal, nasopharyngeal and rectal swabs

Other: Sampling

Non-hospitalized bronchiolitis

Capillary blood samples. Buccal, nasopharyngeal and rectal swabs

Other: Sampling

Bronchiolitis ihospitalized in ICU

Capillary blood samples. Buccal, nasopharyngeal and rectal swabs

Interventions

Single-time sampling of respiratory virus-infected children

Non-hospitalized bronchiolitisSevere bronchiolitis

Eligibility Criteria

Age1 Day - 12 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Bronchiolitis in patient under 12 months old

You may qualify if:

  • Infants \<12 months
  • With bronchiolitis during RSV epidemic season
  • No chronic illness
  • No bronchiolitis medical history
  • Signed consent from parents or legal guardians

You may not qualify if:

  • Chronic respiratory illness
  • Medical history of bronchiolitis or newborn asthma
  • Treatment with immunosuppressants
  • Patient with no social security affiliation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

APHP, Antoine Béclère Hospital

Clamart, 92140, France

RECRUITING

AP-HP,Raymond Poincaré Hospital

Garches, 92380, France

RECRUITING

Réanimation médico-chirurgicale Necker

Paris, 750, France

RECRUITING

MeSH Terms

Conditions

BronchiolitisDysbiosis

Condition Hierarchy (Ancestors)

BronchitisRespiratory Tract InfectionsInfectionsBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Etienne BIZOT, Doctor

    AP-HP Hôpital Antoine Beclere

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Etienne BIZOT, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 30, 2023

First Posted

December 7, 2023

Study Start

December 6, 2024

Primary Completion

March 1, 2026

Study Completion

April 1, 2026

Last Updated

February 26, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations